Smith & Nephew is a global medical technology business dedicated to helping improve people's lives. We have leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma • Orthopaedics Reconstruction - joint replacement systems for knees, hips and shoulders • Advanced Wound Management - wound care treatment and prevention products used to treat hard-to-heal wounds • Sports Medicine - minimally invasive surgery of the joint • Trauma & Extremities - products that help repair broken bones We have almost 11,000 employees and a presence in more than 90 countries. We are a constituent of the UK's FTSE100 and our shares are traded on the London Stock Exchange and through American Depository Receipts on the New York Stock Exchange (LSE: SN, NYSE: SNN)